Open Access Open Access  Restricted Access Subscription Access

Inflammatory Bowel Disease and Skin Cancer:An Assessment of Patient Risk Factors, Knowledge, and Skin Practices


Affiliations
1 Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University School of Medicine, Arkes Family Pavilion Suite 1400, 676 North Saint Clair Street, Chicago, IL 60611, United States
 

Objective: Patients with inflammatory bowel disease (IBD) are at increased risk from skin cancer. Aims include assessing IBD patients' risk factors and knowledge of skin cancer and current skin protection practices to identify gaps in patient education regarding skin cancer prevention in IBD. Methods: IBD patients ≥ 18 years were recruited to complete an online survey. Results: 164 patients (mean age 43.5 years, 63%female) with IBD (67% Crohn's disease, 31% ulcerative colitis, and 2% indeterminate colitis) were included. 12% (n = 19) of patients had a personal history and 34% (n = 55) had a family history of skin cancer. Females scored better on skin protection (16.94/32 versus 14.53/32, p ≤ 0.03) and awareness (35.16/40 versus 32.98/40, p ≤ 0.03). Patients over 40 years old scored better on prevention (17.45/28 versus 15.35/28, p = 0.03). Patients with skin cancer scored better on prevention (20.56/28 versus 15.75/28, p ≤ 0.001) and skin protection (21.47/32 versus 15.33/32, p ≤ 0.001). 61% of patients recognized the link between skin cancer and IBD. Conclusions: The majority of IBD patients are aware of the link between skin cancer and IBD; however, skin protection practices are sub optimal. This emphasizes the role of healthcare professionals in providing further education for skin cancer prevention in the IBD population.
User
Notifications
Font Size

Abstract Views: 49

PDF Views: 0




  • Inflammatory Bowel Disease and Skin Cancer:An Assessment of Patient Risk Factors, Knowledge, and Skin Practices

Abstract Views: 49  |  PDF Views: 0

Authors

Jessica N. Kimmel
Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University School of Medicine, Arkes Family Pavilion Suite 1400, 676 North Saint Clair Street, Chicago, IL 60611, United States
Tiffany H. Taft
Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University School of Medicine, Arkes Family Pavilion Suite 1400, 676 North Saint Clair Street, Chicago, IL 60611, United States
Laurie Keefer
Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University School of Medicine, Arkes Family Pavilion Suite 1400, 676 North Saint Clair Street, Chicago, IL 60611, United States

Abstract


Objective: Patients with inflammatory bowel disease (IBD) are at increased risk from skin cancer. Aims include assessing IBD patients' risk factors and knowledge of skin cancer and current skin protection practices to identify gaps in patient education regarding skin cancer prevention in IBD. Methods: IBD patients ≥ 18 years were recruited to complete an online survey. Results: 164 patients (mean age 43.5 years, 63%female) with IBD (67% Crohn's disease, 31% ulcerative colitis, and 2% indeterminate colitis) were included. 12% (n = 19) of patients had a personal history and 34% (n = 55) had a family history of skin cancer. Females scored better on skin protection (16.94/32 versus 14.53/32, p ≤ 0.03) and awareness (35.16/40 versus 32.98/40, p ≤ 0.03). Patients over 40 years old scored better on prevention (17.45/28 versus 15.35/28, p = 0.03). Patients with skin cancer scored better on prevention (20.56/28 versus 15.75/28, p ≤ 0.001) and skin protection (21.47/32 versus 15.33/32, p ≤ 0.001). 61% of patients recognized the link between skin cancer and IBD. Conclusions: The majority of IBD patients are aware of the link between skin cancer and IBD; however, skin protection practices are sub optimal. This emphasizes the role of healthcare professionals in providing further education for skin cancer prevention in the IBD population.